Investment analysts at StockNews.com initiated coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a research note issued to investors on Sunday. The brokerage set a “hold” rating on the software maker’s stock.
Veradigm Trading Up 0.3 %
NASDAQ MDRX opened at $10.69 on Friday. Veradigm has a 12-month low of $5.01 and a 12-month high of $12.79. The company has a 50 day moving average price of $9.62 and a two-hundred day moving average price of $9.35.
Institutional Investors Weigh In On Veradigm
A hedge fund recently bought a new stake in Veradigm stock. Innealta Capital LLC purchased a new position in shares of Veradigm Inc. (NASDAQ:MDRX – Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 3,974 shares of the software maker’s stock, valued at approximately $38,000.
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Further Reading
- Five stocks we like better than Veradigm
- How to invest in marijuana stocks in 7 steps
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- Are Penny Stocks a Good Fit for Your Portfolio?
- Applied Materials Market Capitulates: Now is the Time to Buy
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- 3 Ultra-High Dividend Yield Stocks for the New Year
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
